LY4006896
27270
Phase 1 small_molecule active
Quick answer
LY4006896 for Parkinson Disease is a Phase 1 program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly and Company
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active